In this longitudinal cohort of older adults with type 2 diabetes and overweight or obesity, increasing levels of plasma NfL and GFAP, but not Aβ42/40 or pTau-181, were associated with decreasing cognitive composite scores and increased odds of MCI or probable dementia. This evidence concerns the gene GFAP and type 2 diabetes mellitus.